GlassScriptPhysician profile
Allan M Rosenbaum
NPI 1528142882
$21,011.77
in general payments reported to CMS, 2019-2025
31 companies · $1,674 in 2025
The $1,674 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,213 · 2020: $2,284 · 2021: $1,465 · 2022: $1,475 · 2023: $9,624 · 2024: $1,276 · 2025: $1,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,925 · Food and Beverage: $4,796 · Travel and Lodging: $1,819 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,925.00 |
| Food and Beverage | $4,796.12 |
| Travel and Lodging | $1,818.98 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $6,648.44 | 2020-2025 | Inspire |
| Ambu INC. | $4,604.11 | 2023 | |
| Intersect Ent, INC. | $2,780.05 | 2019-2021 | |
| Stryker Corporation | $1,423.44 | 2019-2023 | Scopis Ent, Xpress Ent Dilation System, Latera |
| Ambu A/S | $1,125.00 | 2023 | |
| Glaxosmithkline, LLC. | $777.08 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $490.76 | 2021-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $451.20 | 2021-2025 | |
| Optinose US, INC. | $379.24 | 2019-2025 | |
| Galt Pharmaceuticals, LLC | $300.00 | 2023 | Oravig |
| Medtronic, INC. | $253.10 | 2023 | Stealthstation S8 Platform, Propel |
| Aerin Medical INC. | $245.84 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $214.87 | 2021-2025 | Tezspire |
| Acclarent, INC | $191.07 | 2023-2024 | Relieva Spinplus, Trudi Nav Cable, Acclarent Navwire |
| Genentech USA, INC. | $178.38 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $160.19 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Sun Pharmaceutical Industries INC. | $155.74 | 2021-2025 | |
| Pacira Pharmaceuticals Incorporated | $132.55 | 2021-2022 | |
| Alk-Abello, INC | $120.68 | 2021 | |
| Livanova USA, INC. | $89.27 | 2019-2021 | |
| Amgen INC. | $52.12 | 2025 | Tezspire |
| Intuitive Surgical, INC. | $40.00 | 2019 | |
| Merck Sharp & Dohme LLC | $33.57 | 2021 | |
| Phadia US INC. | $25.71 | 2019-2020 | |
| Olympus America INC. | $24.91 | 2019 | |
| Paratek Pharmaceuticals, INC. | $24.29 | 2025 | Xhance |
| Hikma Pharmaceuticals USA | $20.62 | 2025 | Ryaltris |
| Sanara Medtech INC. | $17.93 | 2023 | Celleraterx |
| Pentax of America, INC. | $17.66 | 2021 | |
| Smith+Nephew, INC. | $17.03 | 2025 | Ent Sinus |
| Arbor Pharmaceuticals, INC. | $16.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allan Rosenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.